First Pacific Financial’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.64K Hold
47
– – ﹤0.01% 454
2026
Q2
$8.91K Sell
47
-37
-44% -$6.96K ﹤0.01% 424
2026
Q1
$16.6K Buy
84
+36
+75% +$6.94K ﹤0.01% 324
2025
Q4
$8.79K Sell
48
-2
-4% -$351 ﹤0.01% 341
2025
Q3
$7.56K Buy
50
+2
+4% +$303 ﹤0.01% 344
2025
Q2
$6.64K Hold
48
– – ﹤0.01% 361
2025
Q1
$6.98K Buy
+48
New +$6.94K ﹤0.01% 331

Other funds holding AZN

First Pacific Financial's AZN Position: Q3 2026 in Review

First Pacific Financial held its AstraZeneca (AZN) position steady in Q3 2026 at 47 shares worth $7.64K. The position accounts for ﹤0.01% of the portfolio, ranked #454.

First Pacific Financial first reported a position in AZN in Q1 2025 and has held it in 7 quarters since. The position peaked at $16.6K in Q1 2026. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • First Pacific Financial held 47 shares of AstraZeneca worth $7.64K as of Q3 2026.
  • First Pacific Financial left its AstraZeneca share count unchanged in Q3 2026.
  • AstraZeneca made up ﹤0.01% of First Pacific Financial's portfolio in Q3 2026, its #454 holding.
  • First Pacific Financial first reported a position in AstraZeneca in Q1 2025 and has held it in 7 quarters since.
  • First Pacific Financial's AstraZeneca position peaked at $16.6K in Q1 2026.
  • 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on First Pacific Financial's 13F filing for Q3 2026, filed 14 Oct 2026.